Arivin Therapeutics
PrivateLast Round
Grant
Jan 22, 2026
Total Funding Raised
$3.22M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Arivin Therapeutics is a biotechnology company that develops antimicrobial therapies to treat drug-resistant bacterial infections by targeting bacterial toxins and biofilms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arivin Therapeutics Comparables
Compare Arivin Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| smartbax GmbH | 83% | |
| Santero Therapeutics | 80% | |
| HHV Biotech | 80% |
Arivin Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 22, 2026 | ||||
| Seed | Sep 2, 2025 | ||||
| Accelerator | Jan 27, 2022 |
Arivin Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SPARK Finland | Accelerator |
| INCATE | Accelerator |
| Business Finland | Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 333% MoM, reaching 1.4K.
- May 18, 2026
Monthly visitors increased 349% MoM.
Arivin Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Arivin Therapeutics's valuation, stock price, and market status.
Is Arivin Therapeutics a public or private company?
Arivin Therapeutics is a private company.
What is the current stock price of Arivin Therapeutics?
Arivin Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Arivin Therapeutics worth (valuation)?
Valuation information for Arivin Therapeutics is not publicly available.
Can I buy Arivin Therapeutics stock?
Arivin Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Arivin Therapeutics's last funding round?
Arivin Therapeutics's most recent funding round was Grant on January 22, 2026.
Who are the main investors in Arivin Therapeutics?
Key investors in Arivin Therapeutics include SPARK Finland, INCATE, Business Finland.
Will Arivin Therapeutics IPO soon?
No public IPO plans have been announced for Arivin Therapeutics.
How can I track Arivin Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arivin Therapeutics's secondary market activity and sign up for updates.